Hep C - Conclusions About Milk Thistle

Conclusions About Milk Thistle
A May 2005 review of clinical studies which casts doubt on milk thistle's value has recently been re-released into the press. Alternatively, an extensive amount of research supports the continued usage of this herb at higher dosages. Researchers of the...

Viral Hepatitis
Title: Viral HepatitisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/5/2005

Ultrasound
Title: UltrasoundCategory: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 10/15/2005

Feedster
No Need to Click Here - I'm just claiming my feed at Feedster....

Hepatitis C Patients Taxing Medical System
Title: Hepatitis C Patients Taxing Medical SystemCategory: Health NewsCreated: 12/31/2005 1:59:00 AMLast Editorial Review: 12/31/2005 1:58:37 AM

Hep C - Relative Risks Of Cirrhosis From Non-alcoholic Steatohepatitis

Relative Risks Of Cirrhosis From Non-alcoholic Steatohepatitis
Medical News Today - Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events. These findings are

Tattoo, Piercing And Breast Implantation Infections
Medical News Today - 16th European Congress of Clinical Microbiology and Infectious Diseases Nice, France - In the USA, Canada, Australia and Northern Europe, between 8 and 13% of the population has tattoos and/or piercings, Jean-Baptiste Guiard-Schmid of the Paris

AP Update at 5:58 a.m. EDT
Mojave Daily News - While many people have heard of Hepatitis A and B, not everyone is familiar with Hepatitis C. While types A and B have vaccines, there is no vaccine for type C. According to the Centers for Disease Control, Hepatitis C has now reached epidemic

Antibodies Neutralizing Peginterferon Alfa during Retreatment of
New England Journal of Medicine - To the Editor: Peginterferons are widely used to treat chronic hepatitis C virus (HCV) infection, an important cause of liver cirrhosis and hepatocellular carcinoma. 1 , 2 , 3 , 4 We describe a patient who did not have a virologic response to

Hep C - Shorter Therapy Effective for Genotypes 2 and 3

Shorter Therapy Effective for Genotypes 2 and 3
Genotypes 2 and 3 are much more responsive to current interferon combination therapies. This report details studies that show a shorter course of treatment might be just as effective as longer courses. Researchers continue to refine treatment protocols for HCV...

Newer Hepatitis B Drug Bests Standard Treatment
Title: Newer Hepatitis B Drug Bests Standard TreatmentCategory: Health NewsCreated: 3/9/2006 1:58:00 AMLast Editorial Review: 3/9/2006 1:58:03 AM

A Good AASLD Meeting Summary
This is a terrific overview article regarding the AASLD meeting. Liz Highleyman did a fantastic job of condensing the key aspects and announcements. One of the most interesting updates/corrections of known information is the upward measurement of the number of...

Hepatitis B
Title: Hepatitis BCategory: Diseases and ConditionsCreated: 1/26/2001 11:58:00 AMLast Editorial Review: 9/21/2005

Immunization: National Immunization Awareness Month
Title: Immunization: National Immunization Awareness MonthCategory: Health FactsCreated: 8/1/2005Last Editorial Review: 8/1/2005

Hep C - Medscape Resource Center - Hepatitis C

Medscape Resource Center - Hepatitis C
Spontaneous Viral Clearance Following Acute Hepatitis C Infection: A Systematic Review of Longitudinal Studies from Viral Hepat. 2006;13(1):34-41. A large number of studies have reported on spontaneous

CASL Hepatology Fellowship
Canadian Association for the Study of the Liver Hepatitis C in children

Hepatitis C
Because the symptoms of Hepatitis C infection are usually very mild and can be virtually undetectable, the disease is rarely recognized until it has caused significant damage to the liver.

Hepatitis C Infection (Veterans Affairs)
Hepatitis C Infection Background Hepatitis C (HCV) is a single-stranded RNA virus that is transmitted primarily

Hep C - VX-950 To Get Fast Tracked

VX-950 To Get Fast Tracked
As you may recall we've been saying VX-950 is the revolutionary new therapy to watch for HCV. Now it looks like the FDA agrees this treatment is quite promising and deserving of faster approval than a lesser worthy approach. Another...

Herbal Components are Beneficial in Treating Cirrhosis
An Iranian research study recently concluded that the herbal components of Liv.52 are beneficial in the treatment of cirrhotic patients. The six-month study demonstrated that patients treated with Liv.52 showed better test results than those treated with placebo....

Two Studies Recruiting HCV Patients
Sho-saiko-to is the number one liver remedy in Japan. It has been prescribed to over 1.5 million patients (in Japan, doctors medically prescribe certain natural remedies, just like doctors prescribe pharmaceutical drugs in the U.S.). Based on the large body...

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Hep C - Screening test available to detect an antibody to hepatitis C

Screening test available to detect an antibody to hepatitis C
Inside Bay Area - This is the fourth in a series of columns on medical conditions that are hard to diagnose in women. To read last week's column, visit insidebayarea.com, click on "health" and then click on the headline for "Knowing the warning signs for cervical

Hepatitis C Epidemic Vastly Underestimated By UK Government
Medical News Today - There are more than double the number of people infected with the hepatitis C virus (HCV) in England and Wales than the government has estimated, delegates at the British Society of Gastroenterology's Annual Scientific Meeting were warned. The

Hep C - New Feature: BlinkBits Google Toolbar Button

New Feature: BlinkBits Google Toolbar Button
Save What You Know, Discover What You Dont on ANYTHING from Anywhere with the BlinkBits Google Toolbar Button. Share to any blink, bookmark any page, see what others are sharing on all the blinks, click blink it on stories you like to increase its relevancy and more.

Liver Blood Tests
Title: Liver Blood TestsCategory: Procedures and TestsCreated: 6/2/1998Last Editorial Review: 8/27/2005

SCH 503034 Jumps on the Fast Track
Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on this development....

How to Choose a Doctor
Title: How to Choose a DoctorCategory: Doctor's ViewsCreated: 6/17/2005Last Editorial Review: 8/9/2005

Hep C - MIGENIX Reports Third Quarter Fiscal Year 2006 Results

MIGENIX Reports Third Quarter Fiscal Year 2006 Results
T-Net British Columbia - Mar 08 9:39 AM
Jim DeMesa, M.D., President & CEO of MIGENIX stated, "We continue to make excellent progress in our development programs, with two phase II clinical outcomes expected this year in our MX-3253 program for the treatment of chronic hepatitis C virus infections and a phase III clinical outcome for CPI-226 in catheter-related infections in the first half of calendar 2007. These outcomes have the Save to My Web

Preclinical Studies Presented at AACR Meeting Show Potential of Peregrine's Tarvacin(TM) Plus Radiation or Chemotherapy
[Press Release] PR Newswire via Yahoo! Finance - Apr 03 5:00 AM
Peregrine Pharmaceuticals, Inc. announced today that two groundbreaking preclinical studies being presented at the 97th Annual Meeting of the American Association for Cancer Research demonstrate that a mouse equivalent to its first-in-class anti-phospholipid agent Tarvacin significantly increases survival in cisplatin-resistant breast cancer and radiotherapy-resistant brain cancer when given as Save to My Web

Novelos Therapeutics files IND for new hepatitis C drug
BizJournals - Mar 22 8:23 AM
Novelos Therapeutics Inc., a Newton-based biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, has filed an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration for NOV-205, its second clinical stage compound.Save to My Web

euro adhoc: Intercell AG / Financial Figures/Balance Sheet / Intercell announces preliminary 2005 full year results:
Presseportal - Mar 05 10:29 PM
06.03.2006 Intercell announces preliminary 2005 full year results: Good progress in product development - significant increase in revenues - strong cash ...Save to My Web

MIGENIX Reports Third Quarter Fiscal Year 2006 Results
[Press Release] PR Newswire via Yahoo! Finance - Mar 08 5:42 AM
MIGENIX Inc. , a clinical-stage developer of drugs for infectious and degenerative diseases, reports financial results for the three and nine months ended January 31, 2006 and an update on its programs:Save to My Web

Hep C - HCV Wireless

HCV Wireless
... HCV Wireless converts your vertical market knowledge and requirements into reality using our ... on your core business while HCV Wireless manages your commercialization issues & reduces ...

Diagnosis and Management of the HCV/HIV-Coinfected Patient - AIDS Clinical Care
Diagnosis and Management of the HCV/HIV-Coinfected Patient ... Diagnosis and management of HCV in the patient without comorbidities are under constant evaluation and ... that HIV caregivers ask with regard to the HIV/HCV-coinfected patient ...

Hepatitis C: An Update
For some, the hepatitis C virus is deadly. But for many of the nearly 4 million Americans infected with the virus, it is not life-threatening. ... HCV is responsible for 8,000 to 10,000 deaths per year ...

HCV Advocate: Hepatitis C Living with Hepatitis C
Welcome to HCVadvocate.org Here you will find information on hepatitis C (HCV), hepatitis C treatment options, articles, newsletters; information on living with hepatitis C. ... "An often overlooked and painful component of HCV is stigma ... For some, the stigma of HCV hurts more than HCV itself. This guide discusses the ways in which HCV ...